Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 7 | 2024 | 860 | 1.900 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 203 | 1.070 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2018 | 29 | 1.050 |
Why?
|
| Stroke | 3 | 2019 | 957 | 1.000 |
Why?
|
| Hypothermia, Induced | 2 | 2018 | 158 | 0.950 |
Why?
|
| Heart Arrest | 2 | 2018 | 341 | 0.760 |
Why?
|
| Critical Care | 2 | 2024 | 651 | 0.700 |
Why?
|
| Pyramidal Tracts | 1 | 2020 | 36 | 0.680 |
Why?
|
| Cordotomy | 1 | 2020 | 14 | 0.680 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 87 | 0.680 |
Why?
|
| Cerebral Angiography | 2 | 2016 | 102 | 0.670 |
Why?
|
| Brain Injuries | 1 | 2024 | 762 | 0.600 |
Why?
|
| Neurologic Examination | 1 | 2018 | 196 | 0.580 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 296 | 0.570 |
Why?
|
| Hypovolemia | 1 | 2016 | 11 | 0.560 |
Why?
|
| Meningomyelocele | 1 | 2020 | 222 | 0.550 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2016 | 3 | 0.550 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 22 | 0.540 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 141 | 0.510 |
Why?
|
| Coma | 1 | 2015 | 54 | 0.500 |
Why?
|
| Giant Cell Arteritis | 1 | 2015 | 61 | 0.450 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 433 | 0.440 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 25 | 0.430 |
Why?
|
| Status Epilepticus | 1 | 2015 | 139 | 0.430 |
Why?
|
| Embolism, Air | 1 | 2013 | 25 | 0.430 |
Why?
|
| Body Weight | 1 | 2016 | 966 | 0.420 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 132 | 0.410 |
Why?
|
| Pain | 1 | 2015 | 448 | 0.400 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 373 | 0.370 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2024 | 109 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2047 | 0.320 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2022 | 364 | 0.290 |
Why?
|
| Aged | 9 | 2023 | 18917 | 0.270 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 169 | 0.260 |
Why?
|
| Prognosis | 4 | 2018 | 4498 | 0.260 |
Why?
|
| Humans | 20 | 2024 | 122853 | 0.240 |
Why?
|
| Switzerland | 2 | 2015 | 18 | 0.230 |
Why?
|
| Neurophysiological Monitoring | 1 | 2024 | 37 | 0.220 |
Why?
|
| Middle Aged | 8 | 2020 | 25798 | 0.220 |
Why?
|
| Intensive Care Units | 2 | 2024 | 483 | 0.220 |
Why?
|
| Intracranial Pressure | 1 | 2024 | 180 | 0.210 |
Why?
|
| Male | 12 | 2020 | 59866 | 0.200 |
Why?
|
| Catheter-Related Infections | 1 | 2023 | 129 | 0.200 |
Why?
|
| Monitoring, Physiologic | 1 | 2024 | 359 | 0.190 |
Why?
|
| Child Abuse, Sexual | 2 | 2012 | 34 | 0.190 |
Why?
|
| Lactates | 1 | 2021 | 93 | 0.190 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 73 | 0.190 |
Why?
|
| Cross Infection | 1 | 2023 | 332 | 0.170 |
Why?
|
| Spinal Nerve Roots | 1 | 2020 | 26 | 0.170 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 34 | 0.170 |
Why?
|
| Brain Concussion | 1 | 2022 | 225 | 0.170 |
Why?
|
| Female | 11 | 2020 | 65278 | 0.170 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 290 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2022 | 258 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 1 | 2020 | 130 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2019 | 39 | 0.160 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 143 | 0.160 |
Why?
|
| Survivors | 1 | 2021 | 346 | 0.160 |
Why?
|
| Registries | 2 | 2016 | 1381 | 0.160 |
Why?
|
| Iohexol | 1 | 2016 | 20 | 0.140 |
Why?
|
| Anticonvulsants | 2 | 2022 | 372 | 0.140 |
Why?
|
| Adult | 7 | 2018 | 28926 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3641 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5017 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2022 | 5996 | 0.140 |
Why?
|
| Risk Factors | 3 | 2016 | 9928 | 0.140 |
Why?
|
| Periodicity | 1 | 2016 | 56 | 0.130 |
Why?
|
| Physical Stimulation | 1 | 2015 | 42 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 145 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3319 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6325 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 140 | 0.120 |
Why?
|
| Observation | 1 | 2015 | 41 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2015 | 96 | 0.120 |
Why?
|
| Syndrome | 1 | 2016 | 1123 | 0.110 |
Why?
|
| Neuroimaging | 1 | 2016 | 332 | 0.110 |
Why?
|
| Contrast Media | 1 | 2016 | 469 | 0.110 |
Why?
|
| Criminals | 1 | 2012 | 15 | 0.100 |
Why?
|
| Critical Illness | 1 | 2016 | 594 | 0.090 |
Why?
|
| Crime Victims | 1 | 2012 | 59 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1300 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1378 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1419 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1881 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2094 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2017 | 4673 | 0.080 |
Why?
|
| Epilepsy | 1 | 2016 | 859 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1246 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1581 | 0.070 |
Why?
|
| Seizures | 2 | 2022 | 875 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3083 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 3033 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 6202 | 0.050 |
Why?
|
| New York | 1 | 2022 | 66 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 46 | 0.050 |
Why?
|
| Scalp | 1 | 2022 | 56 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 397 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 422 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2016 | 15927 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12070 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 1242 | 0.040 |
Why?
|
| Ataxin-2 | 1 | 2017 | 8 | 0.040 |
Why?
|
| C9orf72 Protein | 1 | 2017 | 23 | 0.040 |
Why?
|
| DNA Repeat Expansion | 1 | 2017 | 63 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 141 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 708 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 160 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 423 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 748 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1235 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1918 | 0.030 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 13 | 0.030 |
Why?
|
| Exome | 1 | 2017 | 1042 | 0.030 |
Why?
|
| Proteins | 1 | 2017 | 1045 | 0.020 |
Why?
|
| Family Conflict | 1 | 2011 | 18 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1760 | 0.020 |
Why?
|
| Personality | 1 | 2011 | 103 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2011 | 157 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10538 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 2796 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 19037 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 8826 | 0.010 |
Why?
|
| Child | 1 | 2012 | 24168 | 0.010 |
Why?
|